We are live on ! Find out more
GD

Grandfield & Dodd Portfolio holdings

AUM $1.77B
1-Year Est. Return 23.43%
This Fund
S&P 500
This Quarter Est. Return
-3.42%
1 Year Est. Return
+23.43%
3 Year Est. Return
+55.25%
5 Year Est. Return
+78.92%
10 Year Est. Return
+317.48%
AUM
$1.62B
AUM Growth
-$65.6M
Cap. Flow
+$5.57M
Cap. Flow %
0.34%
Top 10 Hldgs %
32.21%
Holding
212
New
5
Increased
55
Reduced
70
Closed
10

Top Sells

Rank Stock Value
1
GEV icon
GE Vernova
GEV
+$5.36M
2
GLW icon
Corning
GLW
+$2.72M
3
MRK icon
Merck
MRK
+$1.72M
4
BLKB icon
Blackbaud
BLKB
+$1.42M
5
MSFT icon
Microsoft
MSFT
+$1.21M

Sector Composition

Rank Sector Weight
1 Technology 28.41%
2 Industrials 17.21%
3 Healthcare 16.4%
4 Financials 10.25%
5 Consumer Staples 7.96%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
IONS icon
101
Ionis Pharmaceuticals
IONS
$9.14B
$1.25M 0.08%
35,887
+1,074
+3% +$40.1K
IWB icon
102
iShares Russell 1000 ETF
IWB
$47.9B
$1.2M 0.07%
3,723
TSLA icon
103
Tesla
TSLA
$1.21T
$1.16M 0.07%
2,877
BMRN icon
104
BioMarin Pharmaceuticals
BMRN
$12B
$1.14M 0.07%
17,392
+731
+4% +$49K
MCD icon
105
McDonald's
MCD
$194B
$1.1M 0.07%
3,802
V icon
106
Visa
V
$697B
$1.09M 0.07%
3,435
WAT icon
107
Waters Corp
WAT
$37.7B
$1.08M 0.07%
2,910
UNP icon
108
Union Pacific
UNP
$175B
$1M 0.06%
4,398
ABBV icon
109
AbbVie
ABBV
$465B
$983K 0.06%
5,532
ETN icon
110
Eaton
ETN
$150B
$977K 0.06%
2,944
-50
-2% -$17.5K
KMB icon
111
Kimberly-Clark
KMB
$37.5B
$866K 0.05%
6,610
-150
-2% -$20.4K
J icon
112
Jacobs Solutions
J
$16.6B
$865K 0.05%
6,538
WLY icon
113
John Wiley & Sons Class A
WLY
$2.76B
$826K 0.05%
18,887
-4,230
-18% -$208K
FUL icon
114
H.B. Fuller
FUL
$3.07B
$798K 0.05%
11,824
PM icon
115
Philip Morris
PM
$312B
$780K 0.05%
6,484
VHT icon
116
Vanguard Health Care ETF
VHT
$18.6B
$772K 0.05%
3,045
RSP icon
117
Invesco S&P 500 Equal Weight ETF
RSP
$98.2B
$750K 0.05%
4,280
+800
+23% +$145K
BLKB icon
118
Blackbaud
BLKB
$1.65B
$736K 0.05%
9,960
-17,350
-64% -$1.42M
BMY icon
119
Bristol-Myers Squibb
BMY
$130B
$733K 0.05%
12,954
-65
-0.5% -$3.63K
NVO
120
Novo Nordisk
NVO
$225B
$730K 0.05%
8,484
-50
-0.6% -$5.41K
EXEL icon
121
Exelixis
EXEL
$14.2B
$728K 0.04%
21,866
+9,846
+82% +$319K
FISV
122
Fiserv Inc
FISV
$28.9B
$708K 0.04%
3,446
GMAB icon
123
Genmab
GMAB
$17.8B
$704K 0.04%
33,733
+1,370
+4% +$30.1K
NEE icon
124
NextEra Energy
NEE
$186B
$703K 0.04%
9,806
WMT icon
125
Walmart Inc
WMT
$900B
$676K 0.04%
7,479

Similar funds

Grandfield & Dodd's Q4 2024 Portfolio in Review

As of Q4 2024, Grandfield & Dodd held 212 positions worth $1.62B, down 3.9% from $1.69B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Grandfield & Dodd's Q4 2024 filing shows 5 new, 55 increased, 70 reduced and 10 closed positions. Its largest new stake was Lamb Weston: 35,022 shares worth $2.34M. The largest sale was GE Vernova, an estimated $5.36M.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Industrials and Healthcare.

  • Grandfield & Dodd's largest Q4 2024 buy was Lamb Weston: 35,022 shares worth $2.34M.
  • Grandfield & Dodd added most to Berkshire Hathaway Class A in Q4 2024, an estimated $6.93M increase.
  • Grandfield & Dodd's biggest Q4 2024 reduction was GE Vernova, cutting an estimated $5.36M.
  • Grandfield & Dodd fully exited People Inc in Q4 2024, selling an estimated $513K.
  • Grandfield & Dodd's ten largest holdings make up 32% of its $1.62B portfolio in Q4 2024.
  • Grandfield & Dodd opened 5 new positions and closed 10 in Q4 2024.
  • Grandfield & Dodd's portfolio value fell 3.9% quarter-over-quarter to $1.62B.

Based on Grandfield & Dodd's 13F filing for Q4 2024, filed 6 Feb 2025.